Related Experiment Video
Updated: Mar 17, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
A single-center experience with undifferentiated embryonal sarcoma of the liver
Melissa D Mathias1, Srikanth R Ambati2, Alexander J Chou2
1Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, New York. mathiasm@mskcc.org.
Abstract:
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.
Related Concept Videos
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells

